Feb 17, 2017 12:30 PM IST | Source: CNBC-TV18

Sell Bharti Infratel, TCS; buy Dishman Pharma: Ashwani Gujral

Ashwani Gujral of is of the view that one may sell Bharti Infratel and Tata Consultancy Services.

Ashwani Gujral of told CNBC-TV18, "Dishman Pharma is a buy with a stoploss of Rs 208 and target of Rs 224. Tata Consultancy Services (TCS) is a sell with a stoploss of Rs 2,450 and target of Rs 2,320."

He further added, "Bharti Infratel is facing heavy selling. So, that is a sell with a stoploss of Rs 316 and look for target of Rs 298."
Follow us on
Available On